Automating Biopharma Manufacturing
Pharmaceutical Technology Europe
; 34(7):15-17, 2022.
Article
Dans Anglais
| ProQuest Central | ID: covidwho-20239318
ABSTRACT
"With the advance of data science enabling factors such as easy access to scalable memory and computing resources;our growing competence in collecting, storing, and contextualizing data;advances in robotics;[and] the quickly evolving method landscape driven by the open-source community, the benefits of automation and simulation are becoming accessible in the notoriously complicated realm of biopharma manufacturing," says Marcel von der Haar, head of product strategy data analytics at Sartorius. "Plug-and-play" capabilities of automation systems, which enable flexible manufacturing and faster technology transfer, are more important than ever, he says. Walvax Biotech's new COVID-19 mRNA vaccine plant in China is another example of an intelligent and digital plant;it uses Honeywell's batch process control, building and energy management solution systems, and digital twins to monitor assets (5). "Automation brings in the data for machine learning to model the dynamic processes of cell growth and map it against the multiple dimensions provided by advanced sensors," explains Brandl.
Pharmacy And Pharmacology; Good Manufacturing Practice; Vaccines; Predictive analytics; Product quality; Artificial intelligence; Digital twins; Technology transfer; Sensors; Life sciences; Process controls; Knowledge management; Software services; Productivity; Manufacturers; Batch processing; Automation; Manufacturing; Human error; Digital technology; United States--US
Collection:
Bases de données des oragnisations internationales
Base de données:
ProQuest Central
Les sujets:
Vaccins
langue:
Anglais
Revue:
Pharmaceutical Technology Europe
Année:
2022
Type de document:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS